Tantawy, M.; Langaee, T.; Wang, D.; Rubinstein, S.M.; Cornell, R.F.; Lenihan, D.; Fradley, M.G.; Gong, Y.
Differential Expression of Circulating miRNAs and Carfilzomib-Related Cardiovascular Adverse Events in Patients with Multiple Myeloma. Int. J. Mol. Sci. 2024, 25, 7795.
https://doi.org/10.3390/ijms25147795
AMA Style
Tantawy M, Langaee T, Wang D, Rubinstein SM, Cornell RF, Lenihan D, Fradley MG, Gong Y.
Differential Expression of Circulating miRNAs and Carfilzomib-Related Cardiovascular Adverse Events in Patients with Multiple Myeloma. International Journal of Molecular Sciences. 2024; 25(14):7795.
https://doi.org/10.3390/ijms25147795
Chicago/Turabian Style
Tantawy, Marwa, Taimour Langaee, Danxin Wang, Samuel M. Rubinstein, Robert F. Cornell, Daniel Lenihan, Michael G. Fradley, and Yan Gong.
2024. "Differential Expression of Circulating miRNAs and Carfilzomib-Related Cardiovascular Adverse Events in Patients with Multiple Myeloma" International Journal of Molecular Sciences 25, no. 14: 7795.
https://doi.org/10.3390/ijms25147795
APA Style
Tantawy, M., Langaee, T., Wang, D., Rubinstein, S. M., Cornell, R. F., Lenihan, D., Fradley, M. G., & Gong, Y.
(2024). Differential Expression of Circulating miRNAs and Carfilzomib-Related Cardiovascular Adverse Events in Patients with Multiple Myeloma. International Journal of Molecular Sciences, 25(14), 7795.
https://doi.org/10.3390/ijms25147795
